A Study to Test How Either a Capsule or a Tablet With NDec (Decitabine and Tetrahydrouridine) Works in the Body of Healthy People

Exclusion Criteria

• •Platelet count greater than (\>) 400\*10\^9/ Liter (L) at visit 1
• •Absolute neutrophil count less than or equal to (≤) 1.5\*10\^9/L at visit 1
• •Female who is:
• •1. pregnant, breast-feeding or intends to become pregnant during the trial or within 6 months after the last dose of trial product or
• •2. of childbearing potential and not using highly effective contraceptive method and whose male partner is not using effective contraception, from screening until 6 months after the last dose of trial product
• •Male of reproductive age with female partner of childbearing potential who does not agree to use condoms and whose female partner of childbearing potential is not using a highly effective contraceptive measure (or adequate contraceptive measure as required by local regulation or practice) from signing the informed consent form (ICF) until 6 months after the last dose.